Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells

Scand J Immunol. 1985 Nov;22(5):585-9. doi: 10.1111/j.1365-3083.1985.tb01918.x.

Abstract

We have investigated whether or not Epstein-Barr virus-transformed lymphoblastoid B cell lines (EBV-BLCL) are able to present Mycobacterium leprae (M. leprae) to antigen-reactive T cell lines and clones. Such EBV-BLCL would provide us with a homogeneous and unlimited source of antigen-presenting cells. Antigen-triggered proliferation of T cells has been studied with co-cultures either with autologous or allogeneic irradiated EBV-BLCL. Our results show that EBV-BLCL are able to present M. leprae as efficiently as peripheral blood mononuclear cells, and that they also function in an HLA-DR-restricted fashion. Apart from their possible in vivo relevance, these results have important practical implications, in particular for the generation and study of M. leprae-reactive T-cell clones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells / immunology*
  • Antigens, Bacterial / immunology
  • B-Lymphocytes / immunology*
  • Cell Transformation, Viral
  • HLA-DR Antigens
  • Herpesvirus 4, Human
  • Histocompatibility Antigens Class II / immunology*
  • Humans
  • Immunity, Cellular
  • Mycobacterium leprae / immunology*
  • T-Lymphocytes / immunology*

Substances

  • Antigens, Bacterial
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II